AAAndreas Androutsellis-Theotokis

Andreas Androutsellis-Theotokis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Andreas Androutsellis-Theotokis has a total of 133 co-authors. Here are the top co-authors by number of shared publications:

  • Steven W. Poser

    Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany

    9 shared publications
  • Jimmy Masjkur

    Department of Medicine, Technische Universität Dresden, Dresden, Germany

    8 shared publications
  • Stefan R. Bornstein

    Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany

    8 shared publications
  • Polyxeni Nikolakopoulou

    Department of Internal Medicine III, Technische Universität Dresden, Dresden, Germany

    5 shared publications
  • Carina Arps-Forker

    Department of Medicine, Technische Universität Dresden, Dresden, Germany

    4 shared publications
  • Deric M. Park

    Department of Neurology, Committee on Clinical Pharmacology and Pharmacogenomics, The University of Chicago, Chicago, Illinois, USA

    4 shared publications

Latest Publications

  • Open Access

    Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery

    by Steven W. Poser, Oliver Otto, Carina Arps‐Forker, Yan Ge, Maik Herbig, Cordula Andree, Konrad Gruetzmann, Melissa F. Adasme, Szymon Stodolak, Polyxeni Nikolakopoulou, et al.

    Cancer cells can switch between signaling pathways to regulate growth under different conditions. In the tumor microenvironment, this likely helps them evade therapies that target specific pathways. We must identify all possible states and utilize them in drug screening programs. One such state is characterized by expression of the transcription factor Hairy and Enhancer of Split 3 ( HES3 ) and sensitivity to HES3 knockdown, and it can be modeled in vitro . Here, we cultured 3 primary human brain cancer cell lines under 3 different culture conditions that maintain low, medium, and high HES3 expression and characterized gene regulation and mechanical phenotype in these states. We assessed gene expression regulation following HES3 knockdown in the HES3 ‐high conditions. We then employed a commonly used human brain tumor cell line to screen Food and Drug Administration (FDA)‐approved compounds that specifically target the HES3 ‐high state. We report that cells from multiple patients behave similarly when placed under distinct culture conditions. We identified 37 FDA‐approved compounds that specifically kill cancer cells in the high‐ HES3 –expression conditions. Our work reveals a novel signaling state in cancer, biomarkers, a strategy to identify treatments against it, and a set of putative drugs for potential repurposing.—Poser, S. W., Otto, O., Arps‐Forker, C., Ge, Y., Herbig, M., Andree, C., Gruetzmann, K., Adasme, M. F., Stodolak, S., Nikolakopoulou, P., Park, D. M., Mcintyre, A., Lesche, M., Dahl, A., Lennig, P., Bornstein, S. R., Schroeck, E., Klink, B., Leker, R. R., Bickle, M., Chrousos, G. P., Schroeder, M., Cannistraci, C. V., Guck, J., Androutsellis‐Theotokis, A. Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery. FASEB J. 33, 9235–9249 (2019). www.fasebj.org


  • Open Access

    Streptozotocin-induced β-cell damage, high fat diet, and metformin administration regulate Hes3 expression in the adult mouse brain

    by Polyxeni Nikolakopoulou, Antonios Chatzigeorgiou, Ioannis Kourtzelis, Louiza Toutouna, Jimmy Masjkur, Carina Arps-Forker, Steven W. Poser, Jan Rozman, Birgit Rathkolb, Juan Antonio Aguilar-Pimentel, et al.

    Diabetes mellitus is a group of disorders characterized by prolonged high levels of circulating blood glucose. Type 1 diabetes is caused by decreased insulin production in the pancreas whereas type 2 diabetes may develop due to obesity and lack of exercise; it begins with insulin resistance whereby cells fail to respond properly to insulin and it may also progress to decreased insulin levels. The brain is an important target for insulin, and there is great interest in understanding how diabetes affects the brain. In addition to the direct effects of insulin on the brain, diabetes may also impact the brain through modulation of the inflammatory system. Here we investigate how perturbation of circulating insulin levels affects the expression of Hes3, a transcription factor expressed in neural stem and progenitor cells that is involved in tissue regeneration. Our data show that streptozotocin-induced β-cell damage, high fat diet, as well as metformin, a common type 2 diabetes medication, regulate Hes3 levels in the brain. This work suggests that Hes3 is a valuable biomarker helping to monitor the state of endogenous neural stem and progenitor cells in the context of diabetes mellitus.


  • Open Access

    The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking

    by Akio Soeda, Justin Lathia, Brian J. Williams, Qiulian Wu, Joseph Gallagher, Andreas Androutsellis-Theotokis, Amber J. Giles, Chunzhang Yang, Zhengping Zhuang, Mark R. Gilbert, et al.

    The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking The p38 signaling pathway effects quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking


  • Hes3 expression in the adult mouse brain is regulated during demyelination and remyelination

    by Louiza Toutouna, Polyxeni Nikolakopoulou, Steven W. Poser, Jimmy Masjkur, Carina Arps-Forker, Maria Troullinaki, Sylvia Grossklaus, Viktoria Bosak, Ulrike Friedrich, Tjalf Ziemssen, et al.


  • Endocrine Pancreas Development and Regeneration: Noncanonical Ideas From Neural Stem Cell Biology

    by Jimmy Masjkur, Steven W. Poser, Polyxeni Nikolakopoulou, George Chrousos, Ronald D. McKay, Stefan R. Bornstein, Peter M. Jones, Andreas Androutsellis-Theotokis

    Loss of insulin-producing pancreatic islet β-cells is a hallmark of type 1 diabetes. Several experimental paradigms demonstrate that these cells can, in principle, be regenerated from multiple endogenous sources using signaling pathways that are also used during pancreas development. A thorough understanding of these pathways will provide improved opportunities for therapeutic intervention. It is now appreciated that signaling pathways should not be seen as “on” or “off” but that the degree of activity may result in wildly different cellular outcomes. In addition to the degree of operation of a signaling pathway, noncanonical branches also play important roles. Thus, a pathway, once considered as “off” or “low” may actually be highly operational but may be using noncanonical branches. Such branches are only now revealing themselves as new tools to assay them are being generated. A formidable source of noncanonical signal transduction concepts is neural stem cells because these cells appear to have acquired unusual signaling interpretations to allow them to maintain their unique dual properties (self-renewal and multipotency). We discuss how such findings from the neural field can provide a blueprint for the identification of new molecular mechanisms regulating pancreatic biology, with a focus on Notch, Hes/Hey, and hedgehog pathways.


  • Open Access

    Hes3 Is Expressed in the Adult Pancreatic Islet and Regulates Gene Expression, Cell Growth, and Insulin Release

    by Jimmy Masjkur, Carina Arps-Forker, Steven W. Poser, Polyxeni Nikolakopoulou, Louiza Toutouna, Ramu Chenna, Triantafyllos Chavakis, Antonios Chatzigeorgiou, Lan-Sun Chen, Anna Dubrovska, et al.


  • Open Access

    Spicing up endogenous neural stem cells: aromatic-turmerone offers new possibilities for tackling neurodegeneration

    by Steven W Poser, Andreas Androutsellis-Theotokis

    There is a growing interest in the therapeutic utility of compounds derived from Curcuma longa, an herb of the Zingiberaceae family that has been part of traditional medicine for centuries. Recent reports suggest that bioactive compounds isolated from the rhizome of these plants can address two key aspects of brain injury following stroke that must be dealt with for functional recovery to occur: the moderation of neuroinflammation, and the mobilization of endogenous stem cells resident in the nervous system. Defining their mechanism of action remains a question, but emerging evidence may point towards one shared with more classic modulators of neural stem cell proliferation and survival.


  • Methods for Assessing the Regenerative Responses of Neural Tissue

    by Steven W. Poser, Maria Adele Rueger, Andreas Androutsellis-Theotokis

    In order to establish novel therapeutic paradigms and advance the field of regenerative medicine, methods for their effective implementation as well as rigorous assessment of outcomes are critical. This is especially evident and challenging in the context of treating complex and devastating neurodegenerative disorders, such as Parkinson’s disease, multiple sclerosis, and ischemic stroke. Stem cell-based approaches offer great promise in addressing these conditions. Here, we demonstrate an approach for identifying factors that mobilize endogenous neural stem cells in the repair and recovery of the central nervous system of rodents, involving site-specific administration of growth factors that activate particular signal transduction pathways, and that allows for the assessment of outcome utilizing magnetic resonance imaging and immunohistochemistry.

  • Open Access

    A Defined, Controlled Culture System for Primary Bovine Chromaffin Progenitors Reveals Novel Biomarkers and Modulators

    by Jimmy Masjkur, Ian Levenfus, Sven Lange, Carina Arps-Forker, Steve Poser, Nan Qin, Vladimir Vukicevic, Triantafyllos Chavakis, Graeme Eisenhofer, Stefan R. Bornstein, et al.

    We present a method to efficiently culture primary chromaffin progenitors from the adult bovine adrenal medulla in a defined, serum-free monolayer system. Tissue is dissociated and plated for expansion under support by the mitogen basic fibroblast growth factor (bFGF). The cultures, although not homogenous, contain a subpopulation of cells expressing the neural stem cell marker Hes3 that also propagate. In addition, Hes3 is also expressed in the adult adrenal medulla from where the tissue is taken. Differentiation is induced by bFGF withdrawal and switching to Neurobasal medium containing B27. Following differentiation, Hes3 expression is lost, and cells acquire morphologies and biomarker expression patterns of chromaffin cells and dopaminergic neurons. We tested the effect of different treatments that we previously showed regulate Hes3 expression and cell number in cultures of fetal and adult rodent neural stem cells. Treatment of the cultures with a combination of Delta4, Angiopoietin2, and a Janus kinase inhibitor increases cell number during the expansion phase without significantly affecting catecholamine content levels. Treatment with cholera toxin does not significantly affect cell number but reduces the ratio of epinephrine to norepinephrine content and increases the dopamine content relative to total catecholamines. These data suggest that this defined culture system can be used for target identification in drug discovery programs and that the transcription factor Hes3 may serve as a new biomarker of putative adrenomedullary chromaffin progenitor cells.


  • Expression of the transcription factor Hes3 in the mouse and human ocular surface, and in pterygium

    by Matina Economopoulou, Jimmy Masjkur, Frederik Raiskup, Doreen Ebermann, Sarama Saha, Mike O. Karl, Richard Funk, Jozsef Jaszai, Triantafyllos Chavakis, Monika Ehrhart-Bornstein, et al.

    Purpose: In this work we examined the presence of the neural stem cell biomarker Hairy and Enhancer of Split 3 (Hes3) in the anterior eye segment and in the aberrant growth condition of the conjunctiva pterygium. Further, we studied the response of Hes3 to irradiation.\ud \ud Materials and methods: Adult mouse and human corneoscleral junction and conjunctiva, as well as human pterygium were prepared for immunohistochemical detection of Hes3 and other markers. Total body irradiation was used to study the changes in the pattern of Hes3 expression.\ud \ud Results: The adult rodent and human eye as well as pterygium, contain a population of cells expressing Hes3. In the human eye, Hes3-expressing (Hes3+) cells are found predominantly in the subconjunctival space spanning over the limbus where they physically associate with blood vessels. The cytoarchitecture of Hes3 + cells is similar to those previously observed in the adult central nervous system. Furthermore, irradiation reduces the number of Hes3 + cells in the subconjunctival space. In contrast, irradiation strongly promotes the nuclear localization of Hes3 in the ciliary body epithelium.\ud \ud Conclusions: Our results suggest that a recently identified signal transduction pathway that regulates neural stem cells and glioblastoma cancer stem cells also operates in the ocular surface, ciliary body, and in pterygium